Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06700213 · ClinicalTrials.gov registry record
Guideline Directed Medical Therapy in Patients With Heart Failure
A clinical trial, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- 300
- Enrollment target
NCT06700213: Completed study, sponsored by Massachusetts General Hospital.
NCT06700213 is a clinical trial that has completed, run by Massachusetts General Hospital. The registered enrollment target is 300 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06700213 has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- 300 participants
- Enrollment target
Study Summary
The TEAM-MGH study will formerly evaluate impact of the GDMT Clinic versus matched usual care patients on the proportion of GDMT administration over a 12 week period in approximately 300 total patients with HF across the spectrum of LVEF (with a minimum of 150 with HFrEF). The study will also assess impact of the GDMT Clinic on health status, functional capacity, biomarker profiles, cardiac remodeling and cardiovascular events.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2023-09-22 |
| Est. Completion | 2025-09-22 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06700213
The ClinicalTrials.gov registry entry for NCT06700213 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT06700213 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06700213 about?
NCT06700213 is a clinical study titled "Guideline Directed Medical Therapy in Patients With Heart Failure". The TEAM-MGH study will formerly evaluate impact of the GDMT Clinic versus matched usual care patients on the proportion of GDMT administration over a 12 week period in approximately 300 total patients with HF across the spectrum of LVEF (with a minimum of 150 with HFrEF). The study will also assess...
What is the current status of trial NCT06700213?
This trial is currently completed. The enrollment target is 300 participants. The study started on 2023-09-22. Estimated completion is 2025-09-22.
Who is sponsoring clinical trial NCT06700213?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.